iRhythm Holdings, Inc. (IRTC) stock
IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/303% below fair value
$89.67−1.16 (-1.28%)
Close on Nov 17, 2026Market cap $2.96BP/E –Yield –
iRhythm price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
iRhythm's price to sales ratio was 3.5× on Nov 11, 2026, against 8.6× a year earlier. Over the last 5 years it ranged from 3.5× to 14.4×, with a median of 7.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.5× | −4.6 |
| 2025 | Dec 31, 2025 | 8.1× | +3.1 |
| 2024 | Dec 31, 2024 | 5.0× | −1.9 |
| 2023 | Dec 29, 2023 | 6.9× | −0.5 |
| 2022 | Dec 30, 2022 | 7.4× | −3.4 |
| 2021 | Dec 31, 2021 | 10.8× | −17.1 |
| 2020 | Dec 31, 2020 | 27.9× | +18.7 |
| 2019 | Dec 31, 2019 | 9.2× | −3.4 |
| 2018 | Dec 31, 2018 | 12.6× | −1.9 |
| 2017 | Dec 29, 2017 | 14.5× | +13.7 |
| 2016 | Dec 30, 2016 | 0.8× | – |
See a number that looks wrong?